The chief market strategist at Freedom Capital Markets breaks down the technicals in this biotech name.
This story was originally reported by CNBC. For the complete coverage and latest updates, visit the original source.
Read the full story at CNBC.
The chief market strategist at Freedom Capital Markets breaks down the technicals in this biotech name.
This story was originally reported by CNBC. For the complete coverage and latest updates, visit the original source.
Read the full story at CNBC.
Originally reported by CNBC. Read the original article